Sartorius has said it will acquire Polyplus for around €2.4bn from private investors to bolster its activities supplying cell and gene therapy companies. Polyplus, which has around 270 employees across France, Belgium, the US and China, develops and produces transfection as well as other DNA/RNA delivery reagents and plasmid DNA. Source: PM Live 6/4/2023